JP2013544799A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544799A5 JP2013544799A5 JP2013535215A JP2013535215A JP2013544799A5 JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5 JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- compound
- pharmaceutical composition
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40706910P | 2010-10-27 | 2010-10-27 | |
| US61/407,069 | 2010-10-27 | ||
| PCT/CA2011/001179 WO2012097427A1 (en) | 2010-10-27 | 2011-10-26 | Compounds and compositions for the treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016153378A Division JP6371344B2 (ja) | 2010-10-27 | 2016-08-04 | がん治療のための化合物および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544799A JP2013544799A (ja) | 2013-12-19 |
| JP2013544799A5 true JP2013544799A5 (OSRAM) | 2014-12-11 |
| JP6007186B2 JP6007186B2 (ja) | 2016-10-12 |
Family
ID=46515034
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535215A Expired - Fee Related JP6007186B2 (ja) | 2010-10-27 | 2011-10-26 | がん治療のための化合物および組成物 |
| JP2016153378A Expired - Fee Related JP6371344B2 (ja) | 2010-10-27 | 2016-08-04 | がん治療のための化合物および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016153378A Expired - Fee Related JP6371344B2 (ja) | 2010-10-27 | 2016-08-04 | がん治療のための化合物および組成物 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9114118B2 (OSRAM) |
| EP (2) | EP3443957B1 (OSRAM) |
| JP (2) | JP6007186B2 (OSRAM) |
| KR (2) | KR101943280B1 (OSRAM) |
| CN (2) | CN105997967B (OSRAM) |
| AU (2) | AU2011356583C1 (OSRAM) |
| BR (1) | BR112013010507A2 (OSRAM) |
| CA (1) | CA2816093C (OSRAM) |
| CL (1) | CL2013001152A1 (OSRAM) |
| DK (2) | DK3443957T3 (OSRAM) |
| EA (2) | EA030038B1 (OSRAM) |
| ES (2) | ES2703257T3 (OSRAM) |
| IL (2) | IL225599A (OSRAM) |
| MX (2) | MX365807B (OSRAM) |
| MY (2) | MY184343A (OSRAM) |
| NZ (1) | NZ610851A (OSRAM) |
| PH (2) | PH12013500766B1 (OSRAM) |
| PL (2) | PL3443957T3 (OSRAM) |
| PT (2) | PT3443957T (OSRAM) |
| SG (2) | SG189538A1 (OSRAM) |
| TR (1) | TR201819987T4 (OSRAM) |
| TW (2) | TWI620563B (OSRAM) |
| WO (1) | WO2012097427A1 (OSRAM) |
| ZA (1) | ZA201303035B (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3443957T3 (da) * | 2010-10-27 | 2020-12-21 | Liminal Biosciences Ltd | Forbindelser og sammensætninger til behandling af cancer |
| TWI742541B (zh) | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
| RU2560702C1 (ru) * | 2014-06-05 | 2015-08-20 | Общество с ограниченной ответственностью "Научно-производственный центр "Амфион" (ООО "НПЦ "Амфион") | Фармацевтическая композиция для применения в онкологии |
| MY187511A (en) * | 2014-10-10 | 2021-09-24 | Prometic Pharma Smt Ltd | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
| PL3203999T3 (pl) * | 2014-10-10 | 2020-07-27 | Liminal Biosciences Limited | Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy |
| KR20170072352A (ko) * | 2014-11-12 | 2017-06-26 | 프로메틱 파마 에스엠티 리미티드 | 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물 |
| CN106267213A (zh) * | 2015-05-27 | 2017-01-04 | 聊城市奥润生物医药科技有限公司 | 环二核苷酸cGAMP在治疗肿瘤联合用药中的应用 |
| WO2019023388A1 (en) | 2017-07-25 | 2019-01-31 | Taris Biomedical Llc | METHODS OF TREATING TUMOR METASTASIS |
| PE20210041A1 (es) | 2017-11-08 | 2021-01-08 | Taris Biomedical Llc | Metodos de tratamiento y terapia de mantenimiento para el cancer de vejiga con gemcitabina |
| CA3121830A1 (en) * | 2018-12-05 | 2020-06-11 | Liminal R&D Biosciences Inc. | Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alstrom syndrome |
| US11246945B2 (en) | 2019-06-07 | 2022-02-15 | National Defense Medical Center | Cisplatin-loaded microbubbles, pharmaceutical composition for treatment of cancer, method for preparing pharmaceutical compositions and method for treating cancer |
| ES2991100T3 (es) | 2019-07-26 | 2024-12-02 | Espervita Therapeutics Inc | Acidos monocarboxílicos y dicarboxílicos de hidrocarburos de cadena larga funcionalizados útiles para la prevención o el tratamiento de enfermedades |
| CA3195137A1 (en) * | 2020-10-06 | 2022-04-14 | Lyne Gagnon | Substituted aromatic compounds and pharmaceutical compositions thereof |
| CA3209453A1 (en) | 2021-01-25 | 2022-07-28 | Espervita Therapeutics, Inc. | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives therof, and their use for the prevention or treatment of disease |
| CN114436822B (zh) * | 2022-01-12 | 2024-04-16 | 厦门稀土材料研究所 | 一枝蒿酮酸和生物碱复盐及其制备方法和用途 |
| AU2024239546A1 (en) * | 2023-03-22 | 2025-10-02 | Uti Limited Partnership | Hydroxyphenyl propanoate compounds for tumour immunotherapy, compositions and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0268907A3 (en) | 1986-11-19 | 1990-03-21 | Carl Richard Thornfeldt | Treatment of disease conditions relating to hyperactive organelles |
| US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
| ITMI20012434A1 (it) * | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
| CN1169768C (zh) * | 2002-04-26 | 2004-10-06 | 中国科学院上海有机化学研究所 | （4－炔基）－芳香酮酸类化合物、合成方法及应用 |
| CA2506897A1 (en) * | 2002-12-27 | 2004-07-15 | Tibotec Bvba | Fluorogenic enzyme substrates and methods of preparation |
| WO2005010202A2 (en) * | 2003-07-16 | 2005-02-03 | Ligand Pharmacueticals Incorporated | PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS |
| WO2005009104A2 (en) * | 2003-07-16 | 2005-02-03 | Ligand Pharmacueticals Incorporated | Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |
| US8198328B2 (en) * | 2004-01-21 | 2012-06-12 | New York University | Treatment of cancer using benzoic acid derivatives |
| ATE530176T1 (de) | 2006-09-01 | 2011-11-15 | Piramal Life Sciences Ltd | Verwendung von kaffeesäure und ihren derivaten gegen krebs |
| ES2657484T3 (es) * | 2007-02-08 | 2018-03-05 | Emisphere Technologies, Inc. | Agentes de administración de ácido fenilalquilcarboxílico |
| PT2299998T (pt) | 2007-11-02 | 2018-04-02 | Prometic Pharma Smt Ltd | Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores |
| WO2009055932A1 (en) | 2007-11-02 | 2009-05-07 | Prometic Biosciences Inc. | Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis |
| EP2231166B1 (en) * | 2007-12-19 | 2013-03-20 | ProMetic BioSciences Inc. | Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| WO2010127440A1 (en) * | 2009-05-04 | 2010-11-11 | Prometic Biosciences Inc. | Substituted aromatic compounds and pharmaceutical uses thereof |
| KR20120090011A (ko) * | 2009-05-04 | 2012-08-16 | 프로메틱 바이오사이언시즈 인코포레이티드 | 3-펜틸페닐아세트산의 염 및 이의 약학적 용도 |
| DK3443957T3 (da) * | 2010-10-27 | 2020-12-21 | Liminal Biosciences Ltd | Forbindelser og sammensætninger til behandling af cancer |
-
2011
- 2011-10-26 DK DK18191792.3T patent/DK3443957T3/da active
- 2011-10-26 MY MYPI2017000606A patent/MY184343A/en unknown
- 2011-10-26 DK DK11856486.3T patent/DK2632452T3/en active
- 2011-10-26 NZ NZ610851A patent/NZ610851A/en not_active IP Right Cessation
- 2011-10-26 CN CN201610353298.3A patent/CN105997967B/zh not_active Expired - Fee Related
- 2011-10-26 EP EP18191792.3A patent/EP3443957B1/en active Active
- 2011-10-26 SG SG2013032354A patent/SG189538A1/en unknown
- 2011-10-26 BR BR112013010507A patent/BR112013010507A2/pt not_active Application Discontinuation
- 2011-10-26 ES ES11856486T patent/ES2703257T3/es active Active
- 2011-10-26 EA EA201370103A patent/EA030038B1/ru not_active IP Right Cessation
- 2011-10-26 CA CA2816093A patent/CA2816093C/en active Active
- 2011-10-26 PT PT181917923T patent/PT3443957T/pt unknown
- 2011-10-26 ES ES18191792T patent/ES2837599T3/es active Active
- 2011-10-26 EA EA201791585A patent/EA035494B1/ru not_active IP Right Cessation
- 2011-10-26 PH PH1/2013/500766A patent/PH12013500766B1/en unknown
- 2011-10-26 TW TW106101424A patent/TWI620563B/zh not_active IP Right Cessation
- 2011-10-26 WO PCT/CA2011/001179 patent/WO2012097427A1/en not_active Ceased
- 2011-10-26 CN CN201180052340.3A patent/CN103347509B/zh not_active Expired - Fee Related
- 2011-10-26 MX MX2013004832A patent/MX365807B/es active IP Right Grant
- 2011-10-26 KR KR1020187001526A patent/KR101943280B1/ko not_active Expired - Fee Related
- 2011-10-26 PT PT11856486T patent/PT2632452T/pt unknown
- 2011-10-26 KR KR1020137013238A patent/KR101821646B1/ko not_active Expired - Fee Related
- 2011-10-26 US US13/882,355 patent/US9114118B2/en not_active Expired - Fee Related
- 2011-10-26 TR TR2018/19987T patent/TR201819987T4/tr unknown
- 2011-10-26 PL PL18191792T patent/PL3443957T3/pl unknown
- 2011-10-26 SG SG10201807622WA patent/SG10201807622WA/en unknown
- 2011-10-26 JP JP2013535215A patent/JP6007186B2/ja not_active Expired - Fee Related
- 2011-10-26 MX MX2019007010A patent/MX381345B/es unknown
- 2011-10-26 TW TW100138943A patent/TWI578983B/zh not_active IP Right Cessation
- 2011-10-26 PL PL11856486T patent/PL2632452T3/pl unknown
- 2011-10-26 MY MYPI2013001522A patent/MY162420A/en unknown
- 2011-10-26 AU AU2011356583A patent/AU2011356583C1/en not_active Ceased
- 2011-10-26 EP EP11856486.3A patent/EP2632452B1/en active Active
-
2013
- 2013-04-07 IL IL225599A patent/IL225599A/en active IP Right Grant
- 2013-04-25 ZA ZA2013/03035A patent/ZA201303035B/en unknown
- 2013-04-26 CL CL2013001152A patent/CL2013001152A1/es unknown
-
2015
- 2015-07-13 US US14/797,957 patent/US9439882B2/en not_active Expired - Fee Related
-
2016
- 2016-03-10 AU AU2016201556A patent/AU2016201556B2/en not_active Ceased
- 2016-08-04 JP JP2016153378A patent/JP6371344B2/ja not_active Expired - Fee Related
- 2016-11-22 PH PH12016502324A patent/PH12016502324B1/en unknown
-
2017
- 2017-03-10 IL IL251083A patent/IL251083B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544799A5 (OSRAM) | ||
| JP2014528467A5 (OSRAM) | ||
| NZ610851A (en) | Compounds and compositions for the treatment of cancer | |
| JP2014513704A5 (OSRAM) | ||
| JP2013507423A5 (OSRAM) | ||
| MX2009004715A (es) | Compuestos heterociclicos como agentes antiinflamatorios. | |
| GEP20115174B (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| JP2013510860A5 (OSRAM) | ||
| JP2017528475A5 (OSRAM) | ||
| GEP201706639B (en) | Heterocyclic compounds and uses thereof | |
| JP2006504624A5 (OSRAM) | ||
| JP2015522650A5 (OSRAM) | ||
| JP2014528466A5 (OSRAM) | ||
| JP2008535902A5 (OSRAM) | ||
| JP2016513737A5 (OSRAM) | ||
| JP2013543845A5 (OSRAM) | ||
| NZ710745A (en) | Pyrrolobenzodiazepines and conjugates thereof | |
| JP2015531366A5 (OSRAM) | ||
| JP2012515776A5 (OSRAM) | ||
| JP2011251990A5 (OSRAM) | ||
| JP2009536221A5 (OSRAM) | ||
| GEP201606540B (en) | New indolizine derivatives, method for their preparation and pharmaceutical compositions containing thereof | |
| JP2009529540A5 (OSRAM) | ||
| JP2014524441A5 (OSRAM) | ||
| JP2015504081A5 (OSRAM) |